-

IFF Pharma Solutions to Showcase Plant-Based Dietary Supplement Ingredients and Technical Expertise at Vitafoods™ Europe 2025

Improving the World of Dietary Supplements with a Breadth of Proven Brands.

NEW YORK--(BUSINESS WIRE)--IFF (NYSE: IFF) Pharma Solutions is excited to announce its participation at Vitafoods™ Europe 2025, the premier global nutraceutical event. The team will showcase its cutting-edge dietary supplement plant-based ingredients portfolio of innovative and trusted brands including SeaGel®, VERDIGEL™ SC, GRINDSTED® Pectin Premium, Ac-Di-Sol®, Avicel®, Accelerate®, and METHOCEL™ in hall 4 at booth 4F25, May 20-22, at the Fira Barcelona Gran Via.

"We are excited to highlight vivid examples of how our high-quality functional ingredients and technical expertise help our customers produce superior supplements," said Firat Nalbantoglu, EMEA commercial leader, IFF Pharma Solutions. "Our technical and commercial experts look forward to offering solutions for formulation and processing challenges. If you aim to enhance efficacy and bioavailability in your dietary supplements, we invite you to discover new possibilities with us."

IFF Pharma Solutions is committed to advancing the dietary supplement industry with its portfolio of high-performance ingredients, offering plant-based solutions and vegan alternatives, as well as reliable technologies for immediate and controlled release:

  • SeaGel® and VERDIGEL™ SC: These plant-based alternatives to gelatin offer clean-label, non-GMO solutions for superior quality and high performance vegan softgels.
  • GRINDSTED® Pectin Premium: A renowned, citrus-sourced ingredient for plant-based gummies that delivers an excellent consumer experience.
  • Avicel®: A cellulose-based tablet binder and filler, Avicel® ensures the production of small, high-quality tablets with low-dusting and efficient tableting processes. Avicel® acts as a suspending agent, enhancing the stability and efficacy of liquid formulations.
  • Ac-Di-Sol®: A non-GMO cellulose-based tablet disintegrant that delivers nutritional ingredients faster.
  • METHOCEL™: A versatile cellulose-based solution for vegetarian hard capsules and controlled-release tablet matrices – resistant to heat and humidity conditions.
  • Accelerate®: A cellulose-based super disintegrant for immediate release.

Visit here to learn more about IFF Pharma Solutions.

Welcome to IFF
At IFF (NYSE: IFF), we make joy through science, creativity and heart. As the global leader in flavors, fragrances, food ingredients, health and biosciences, we deliver groundbreaking, sustainable innovations that elevate everyday products—advancing wellness, delighting the senses and enhancing the human experience. Learn more at iff.com, LinkedIn, Instagram and Facebook.

©2025 International Flavors & Fragrances Inc. (IFF). IFF, the IFF Logo, and all trademarks and service marks denoted with ™, SM or ® are owned by IFF or affiliates of IFF unless otherwise noted. All Rights Reserved.

Contacts

Britta Meys
Global Communications Lead EMEA
+49 151 14486359
britta.meys@iff.com

International Flavors & Fragrances

NYSE:IFF

Release Versions

Contacts

Britta Meys
Global Communications Lead EMEA
+49 151 14486359
britta.meys@iff.com

More News From International Flavors & Fragrances

Tastepoint by IFF Predicts Ten Flavor Trends for 2026

PHILADELPHIA--(BUSINESS WIRE)--Tastepoint by IFF (NYSE: IFF), a leader in innovative flavor creations and taste solutions, has identified ten flavors expected to shape the North American food and beverage landscape in 2026. These predictions spotlight flavors anticipated to trend in retail, food service and beyond throughout the coming year. “To continue delivering product development solutions that meet consumers’ unique and changing needs, we stay attuned to industry and market trends, keepin...

IFF to Release Fourth Quarter & Full Year 2025 Results on Feb. 11, 2026; IFF to Present at 2026 CAGNY Conference on Feb. 19, 2026

NEW YORK--(BUSINESS WIRE)--IFF (NYSE:IFF) today announced that it will release its fourth quarter and full year 2025 earnings results following the market close on Wednesday, Feb. 11, 2026. The management team will host a live webcast on Thursday, Feb. 12, 2026, at 9:00 a.m. ET to discuss results and outlook with the investor community. IFF also announced today that the Company’s management will speak at the Consumer Analyst Group of New York (CAGNY) conference on Thursday, Feb. 19, 2026 at 1:0...

IFF Introduces Smart Dosing Robot to Transform Fragrance Production

CHIN BEE, Singapore--(BUSINESS WIRE)--IFF (NYSE: IFF) — a global leader in flavors, fragrances, food ingredients, health and biosciences, has implemented the Colibri robot in its Chin Bee production facility. This advanced industrial dosing system can produce fragrance sample batches on demand in minutes, reimagining and expediting the fragrance development journey for local, regional and global customers in Greater Asia. The new robotic system, installed at the company's cross-category Scent a...
Back to Newsroom